Synthesis and in vitro evaluation of a selective antagonist and the corresponding radioligand for the prostaglandin D2 receptor CRTH2
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Synthesis and in vitro evaluation of a selective antagonist and the corresponding radioligand for the prostaglandin D2 receptor CRTH2. / Ulven, Trond; Gallen, Michael J; Nielsen, Mads C; Merten, Nicole; Schmidt, Carola; Mohr, Klaus; Tränkle, Christian; Kostenis, Evi.
In: Bioorganic & Medicinal Chemistry Letters, Vol. 17, No. 21, 01.11.2007, p. 5924-5927.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Synthesis and in vitro evaluation of a selective antagonist and the corresponding radioligand for the prostaglandin D2 receptor CRTH2
AU - Ulven, Trond
AU - Gallen, Michael J
AU - Nielsen, Mads C
AU - Merten, Nicole
AU - Schmidt, Carola
AU - Mohr, Klaus
AU - Tränkle, Christian
AU - Kostenis, Evi
PY - 2007/11/1
Y1 - 2007/11/1
N2 - Synthesis and preliminary in vitro biological evaluation of a selective high-affinity CRTH2 antagonist is described. The stability of an N-benzyl group facilitated synthesis of the corresponding radioligand by tritiation of a brominated precursor. The compound [(3)H]TRQ11238 represents the first selective CRTH2 antagonist radioligand and exhibited a specific radioactivity of 52 Ci/mmol and a pK(d) of 9.0 Udgivelsesdato: 2007-Nov-1
AB - Synthesis and preliminary in vitro biological evaluation of a selective high-affinity CRTH2 antagonist is described. The stability of an N-benzyl group facilitated synthesis of the corresponding radioligand by tritiation of a brominated precursor. The compound [(3)H]TRQ11238 represents the first selective CRTH2 antagonist radioligand and exhibited a specific radioactivity of 52 Ci/mmol and a pK(d) of 9.0 Udgivelsesdato: 2007-Nov-1
KW - Drug Evaluation, Preclinical
KW - Indoles
KW - Radioligand Assay
KW - Receptors, Immunologic
KW - Receptors, Prostaglandin
KW - Sulfonamides
U2 - 10.1016/j.bmcl.2007.07.080
DO - 10.1016/j.bmcl.2007.07.080
M3 - Journal article
VL - 17
SP - 5924
EP - 5927
JO - Bioorganic & Medicinal Chemistry Letters
JF - Bioorganic & Medicinal Chemistry Letters
SN - 0960-894X
IS - 21
ER -
ID: 189158552